Shares in AstraZeneca were down 1.3 percent in midday deals on London's top-tier FTSE 100 index, which was trading one ...

Pharmaceutical giant AstraZeneca said that the head of its China operations had been detained, after reports the firm was ...

Ozempic and Wegovy, made by Novo Nordisk, are now listed as available across all doses on the FDA’s drug shortage list. But ...

AstraZeneca plans a new investment of $2 billion in the U.S., one of the first major foreign companies to shift spending to ...

"It is important to raise awareness of early screening among high-risk groups," he added. Experts suggested men age 50 and ...

Lung cancer remained the most prevalent type with 5,707 new cases recorded in 2022 while colorectal cancer was third.

Merck KGaA’s $70 million bet on a treatment for a rare, locally aggressive cancer has delivered a phase 3 win ... $70 million ...

AstraZeneca is under scrutiny in China — as its top executive there and other personnel are being investigated by authorities ...

British pharmaceutical giant AstraZeneca on Tuesday said it takes “very seriously” China’s investigations into potential ...

The head of multinational pharmaceutical giant AstraZeneca's China arm is under investigation in the country, the firm said.

In China, the incidence rate is lower than that ... said during an interview with The-Paper.cn that about 70 percent of liver cancer patients are at an advanced or late stage when seeking ...